Medpace Holdings revenue and financials

MEDP · NASDAQ · USD

Compare Medpace Holdings
$610.54Change from previous close: −3.70%Absolute change: −$23.44

Close · November 20, 2026

In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.

Annual revenue · 2025: $2.53B
  1. $421.58M2016
  2. $436.15M2017
  3. $704.59M2018
  4. $860.97M2019
  5. $925.93M2020
  6. $1.14B2021
  7. $1.46B2022
  8. $1.89B2023
  9. $2.11B2024
  10. $2.53B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+19.97%
2025 vs 2024
Net income growth
+11.56%
2025 vs 2024
Net margin
17.8%
2024: 19.2%

How Medpace Holdings is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue2,5302,1091,8861,4601,142926861705436422
Cost of revenue732682638535441354321252212199
Gross profit1,7981,4271,248925701571540452175172
Selling, general and administrative19818016113110892.295.275.763.461.5
Operating income53544733727919916712710164.952.5
EBIT53544733727919916712710164.952.5
EBITDA563476363301220187150140111111
Interest expense——0.52.90.1—1.68.27.619.4
Pre-tax income54247633628320216912594.056.922.0
Income tax91.371.552.937.520.023.124.420.817.88.5
Net income45140428324518214510073.239.113.4
Net income to common shareholders45140428324518114510072.939.013.4
Basic EPS15.6413.069.207.575.064.072.792.051.000.38
Diluted EPS15.2812.638.887.284.813.842.671.970.980.37
Average shares (basic)28.831.030.732.435.935.635.935.539.135.7
Average shares (diluted)29.532.031.833.737.737.737.636.939.836.3

Companies in the group: same industry, similar size